Navigation Links
Callisto in Medical Technology

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

... NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a dev... relapsed or refractory multiple myeloma patients. callisto earlier announced in June, 2006 interim data from ... abdominal pain and valvular heart disease. About callisto Pharmaceuticals, Inc. ...

Callisto Reports on Second-Quarter 2007 Milestones

...grams NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a dev...g (synthetic molecule) of uroguanylin developed by callisto scientists, and is proprietary to Callisto. Guanil... being evaluated in animal models of GI disorders. callisto plans to initiate clinical trials of Guanilib in e...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

... NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a dev...erested in participating in this trial." Currently callisto has enrolled 31 patients of the 40 subjects planne... relapsed or refractory multiple myeloma patients. callisto earlier announced in June, 2006 interim data from ...

Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis

...e drug is currently in preclinical development and callisto intends to move the drug into clinical trials in u...proprietary program that was developed in-house by callisto scientists and the company owns 100% of the worldw...ib in GI inflammatory diseases and colon cancer. callisto believes that Guanilib is presently the best physi...

Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma

..., S. Hong, F. Samaniego, J. Romaguera and Q. Yi. callisto is a biopharmaceutical company focused on the deve...cute leukemia, a currently incurable blood cancer. callisto initiated a clinical trial of L- Annamycin in pedi...compared to currently available drug alternatives. callisto also has drugs in preclinical development for gast...
Other Tags
(Date:4/18/2014)... Fraser University psychologists have made a brain-related discovery ... attention-deficit disorders. , This discovery opens up the ... or suppress a specific brain activity that the ... , The Journal of Neuroscience has ... John McDonald, an associate professor of psychology and ...
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... of Experimental Biology and Medicine a ... and Paul Kenis in the Institute of Genomic ... of Illinois Urbana-Champaign describe their recent work on ... variety of cell functions including energy metabolism, signaling, ... in regulating normal cellular behavior, redox status has ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... one in five infants in the United States annually ... several months after birth. Research into probiotic use for ... April 1, 2014 issue of the British Medical ... "Probiotics and Infant Colic," concluding that the use of ... did not reduce crying or fussing in infants ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
(Date:4/17/2014)... April 17, 2014The development of stem cell therapies to ... to characterize stem cell populations based on cell surface ... a new marker that is highly expressed in a ... blood, which they describe in an article in ... Ann Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... N.M. A credit-card-sized anthrax detection cartridge developed at ... business makes testing safer, easier, faster and cheaper. ... anthrax, is commonly found in soils all over the ... in both humans and animals. The bacteria can survive ... B. anthracis may occur through skin contact, ...
(Date:4/17/2014)... bone marrow need to produce hydrogen sulfide in order ... a new study from the Center for Craniofacial Molecular ... USC. , Professor Songtao Shi, principal investigator on the ... the cells governs the flow of calcium ions. The ... results in osteogenesis, or the creation of new bone ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3
Other Contents